5-[6-[[(1R)-1-cyclobutylethyl]amino]-7-ethenyl-8-[(5S)-2-[(3S)-3-methylcyclohexyl]-5-(trifluoromethyl)pyrrolidin-1-yl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one

C27H35F3N8O2 — CID 134468199

IUPAC5-[6-[[(1R)-1-cyclobutylethyl]amino]-7-ethenyl-8-[(5S)-2-[(3S)-3-methylcyclohexyl]-5-(trifluoromethyl)pyrrolidin-1-yl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one
SMILESC=Cn1c(N2C(C3CCC[C@H](C)C3)CC[C@H]2C(F)(F)F)nc2nc(-c3n[nH]c(=O)o3)nc(N[C@H](C)C3CCC3)c21
InChIInChI=1S/C27H35F3N8O2/c1-4-37-20-21(31-15(3)16-8-6-9-16)32-23(24-35-36-26(39)40-24)33-22(20)34-25(37)38-18(11-12-19(38)27(28,29)30)17-10-5-7-14(2)13-17/h4,14-19H,1,5-13H2,2-3H3,(H,36,39)(H,31,32,33)/t14-,15+,17?,18?,19-/m0/s1
InChIKeyCZPVCGFRWDXCTC-YHGYTCJYSA-N
MW560.63 g/mol
LogP5.60
Rot. Bonds7

About 5-[6-[[(1R)-1-cyclobutylethyl]amino]-7-ethenyl-8-[(5S)-2-[(3S)-3-methylcyclohexyl]-5-(trifluoromethyl)pyrrolidin-1-yl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one

5-[6-[[(1R)-1-cyclobutylethyl]amino]-7-ethenyl-8-[(5S)-2-[(3S)-3-methylcyclohexyl]-5-(trifluoromethyl)pyrrolidin-1-yl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one (PubChem CID 134468199) has the molecular formula C27H35F3N8O2 and a molecular weight of 560.63 g/mol. Its IUPAC name is 5-[6-[[(1R)-1-cyclobutylethyl]amino]-7-ethenyl-8-[(5S)-2-[(3S)-3-methylcyclohexyl]-5-(trifluoromethyl)pyrrolidin-1-yl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one.

Molecular Properties

Compound Name5-[6-[[(1R)-1-cyclobutylethyl]amino]-7-ethenyl-8-[(5S)-2-[(3S)-3-methylcyclohexyl]-5-(trifluoromethyl)pyrrolidin-1-yl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one
PubChem CID134468199
Molecular FormulaC27H35F3N8O2
Molecular Weight560.63 g/mol
Exact Mass560.28
IUPAC Name5-[6-[[(1R)-1-cyclobutylethyl]amino]-7-ethenyl-8-[(5S)-2-[(3S)-3-methylcyclohexyl]-5-(trifluoromethyl)pyrrolidin-1-yl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one
SMILESC=Cn1c(N2C(C3CCC[C@H](C)C3)CC[C@H]2C(F)(F)F)nc2nc(-c3n[nH]c(=O)o3)nc(N[C@H](C)C3CCC3)c21
InChIInChI=1S/C27H35F3N8O2/c1-4-37-20-21(31-15(3)16-8-6-9-16)32-23(24-35-36-26(39)40-24)33-22(20)34-25(37)38-18(11-12-19(38)27(28,29)30)17-10-5-7-14(2)13-17/h4,14-19H,1,5-13H2,2-3H3,(H,36,39)(H,31,32,33)/t14-,15+,17?,18?,19-/m0/s1
InChIKeyCZPVCGFRWDXCTC-YHGYTCJYSA-N
XLogP5.60
TPSA117.76 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms40
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500560.63
LogP ≤ 55.60
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Analyze 5-[6-[[(1R)-1-cyclobutylethyl]amino]-7-ethenyl-8-[(5S)-2-[(3S)-3-methylcyclohexyl]-5-(trifluoromethyl)pyrrolidin-1-yl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[6-[[(1R)-1-cyclobutylethyl]amino]-7-ethenyl-8-[(5S)-2-[(3S)-3-methylcyclohexyl]-5-(trifluoromethyl)pyrrolidin-1-yl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one?
The IUPAC name of 5-[6-[[(1R)-1-cyclobutylethyl]amino]-7-ethenyl-8-[(5S)-2-[(3S)-3-methylcyclohexyl]-5-(trifluoromethyl)pyrrolidin-1-yl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one (CID 134468199) is 5-[6-[[(1R)-1-cyclobutylethyl]amino]-7-ethenyl-8-[(5S)-2-[(3S)-3-methylcyclohexyl]-5-(trifluoromethyl)pyrrolidin-1-yl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one.
What is the SMILES notation for 5-[6-[[(1R)-1-cyclobutylethyl]amino]-7-ethenyl-8-[(5S)-2-[(3S)-3-methylcyclohexyl]-5-(trifluoromethyl)pyrrolidin-1-yl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one?
The canonical SMILES for 5-[6-[[(1R)-1-cyclobutylethyl]amino]-7-ethenyl-8-[(5S)-2-[(3S)-3-methylcyclohexyl]-5-(trifluoromethyl)pyrrolidin-1-yl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one is C=Cn1c(N2C(C3CCC[C@H](C)C3)CC[C@H]2C(F)(F)F)nc2nc(-c3n[nH]c(=O)o3)nc(N[C@H](C)C3CCC3)c21.
What is the InChIKey of 5-[6-[[(1R)-1-cyclobutylethyl]amino]-7-ethenyl-8-[(5S)-2-[(3S)-3-methylcyclohexyl]-5-(trifluoromethyl)pyrrolidin-1-yl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one?
The InChIKey is CZPVCGFRWDXCTC-YHGYTCJYSA-N. The full InChI is InChI=1S/C27H35F3N8O2/c1-4-37-20-21(31-15(3)16-8-6-9-16)32-23(24-35-36-26(39)40-24)33-22(20)34-25(37)38-18(11-12-19(38)27(28,29)30)17-10-5-7-14(2)13-17/h4,14-19H,1,5-13H2,2-3H3,(H,36,39)(H,31,32,33)/t14-,15+,17?,18?,19-/m0/s1.
What are the key properties of 5-[6-[[(1R)-1-cyclobutylethyl]amino]-7-ethenyl-8-[(5S)-2-[(3S)-3-methylcyclohexyl]-5-(trifluoromethyl)pyrrolidin-1-yl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one?
5-[6-[[(1R)-1-cyclobutylethyl]amino]-7-ethenyl-8-[(5S)-2-[(3S)-3-methylcyclohexyl]-5-(trifluoromethyl)pyrrolidin-1-yl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one has a molecular weight of 560.63 g/mol, XLogP of 5.60, 7 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[6-[[(1R)-1-cyclobutylethyl]amino]-7-ethenyl-8-[(5S)-2-[(3S)-3-methylcyclohexyl]-5-(trifluoromethyl)pyrrolidin-1-yl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one is sourced from PubChem (CID 134468199), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).